Carlson Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $396K | Sell |
513
-1,936
| -79% | -$1.6M | 0.02% | 83 |
|
|
2024
Q3 | $2.17M | Buy |
2,449
+58
| +2% | +$52.1K | 0.09% | 36 |
|
|
2024
Q2 | $2.16M | Buy |
2,391
+5
| +0.2% | +$4K | 0.1% | 31 |
|
|
2024
Q1 | $1.86M | Sell |
2,386
-234
| -9% | -$167K | 0.09% | 35 |
|
|
2023
Q4 | $1.53M | Sell |
2,620
-33
| -1% | -$19.3K | 0.08% | 68 |
|
|
2023
Q3 | $1.42M | Buy |
2,653
+4
| +0.2% | +$2.06K | 0.08% | 61 |
|
|
2023
Q2 | $1.24M | Sell |
2,649
-992
| -27% | -$416K | 0.08% | 65 |
|
|
2023
Q1 | $1.25M | Buy |
3,641
+7
| +0.2% | +$2.36K | 0.08% | 61 |
|
|
2022
Q4 | $1.33M | Sell |
3,634
-2
| -0.1% | -$709 | 0.1% | 59 |
|
|
2022
Q3 | $1.18M | Buy |
3,636
+99
| +3% | +$31.4K | 0.1% | 58 |
|
|
2022
Q2 | $1.15M | Sell |
3,537
-504
| -12% | -$151K | 0.1% | 61 |
|
|
2022
Q1 | $1.16M | Buy |
4,041
+20
| +0.5% | +$5.15K | 0.1% | 57 |
|
|
2021
Q4 | $1.11M | Buy |
4,021
+34
| +0.9% | +$8.62K | 0.1% | 58 |
|
|
2021
Q3 | $921K | Buy |
3,987
+7
| +0.2% | +$1.73K | 0.1% | 60 |
|
|
2021
Q2 | $913K | Buy |
3,980
+28
| +0.7% | +$5.62K | 0.13% | 51 |
|
|
2021
Q1 | $738K | Buy |
3,952
+83
| +2% | +$16.2K | 0.13% | 57 |
|
|
2020
Q4 | $644K | Buy |
3,869
+23
| +0.6% | +$3.43K | 0.12% | 60 |
|
|
2020
Q3 | $569K | Buy |
3,846
+9
| +0.2% | +$1.39K | 0.12% | 62 |
|
|
2020
Q2 | $627K | Buy |
3,837
+109
| +3% | +$16.7K | 0.14% | 53 |
|
|
2020
Q1 | $607K | Sell |
3,728
-125
| -3% | -$17.2K | 0.15% | 48 |
|
|
2019
Q4 | $506K | Buy |
3,853
+26
| +0.7% | +$3.01K | 0.11% | 53 |
|
|
2019
Q3 | $428K | Buy |
3,827
+33
| +0.9% | +$3.67K | 0.1% | 56 |
|
|
2019
Q2 | $420K | Sell |
3,794
-48
| -1% | -$5.65K | 0.1% | 54 |
|
|
2019
Q1 | $499K | Sell |
3,842
-1,565
| -29% | -$190K | 0.12% | 48 |
|
|
2018
Q4 | $626K | Sell |
5,407
-1,181
| -18% | -$132K | 0.18% | 37 |
|
|
2018
Q3 | $707K | Sell |
6,588
-79
| -1% | -$7.9K | 0.18% | 37 |
|
|
2018
Q2 | $569K | Buy |
6,667
+26
| +0.4% | +$2.14K | 0.15% | 39 |
|
|
2018
Q1 | $514K | Sell |
6,641
-160
| -2% | -$12.9K | 0.14% | 43 |
|
|
2017
Q4 | $574K | Buy |
6,801
+92
| +1% | +$7.83K | 0.15% | 41 |
|
|
2017
Q3 | $574K | Buy |
6,709
+3,899
| +139% | +$320K | 0.17% | 36 |
|
|
2017
Q2 | $231K | Sell |
2,810
-98
| -3% | -$8K | 0.07% | 69 |
|
|
2017
Q1 | $245K | Buy |
2,908
+5
| +0.2% | +$400 | 0.08% | 50 |
|
|
2016
Q4 | $214K | Sell |
2,903
-100
| -3% | -$7.45K | 0.07% | 52 |
|
|
2016
Q3 | $241K | Hold |
3,003
| – | – | 0.08% | 52 |
|
|
2016
Q2 | $236K | Hold |
3,003
| – | – | 0.08% | 53 |
|
|
2016
Q1 | $216K | Sell |
3,003
-211
| -7% | -$16K | 0.08% | 53 |
|
|
2015
Q4 | $271K | Hold |
3,214
| – | – | 0.1% | 50 |
|
|
2015
Q3 | $269K | Hold |
3,214
| – | – | 0.11% | 47 |
|
|
2015
Q2 | $268K | Sell |
3,214
-100
| -3% | -$7.62K | 0.1% | 50 |
|
|
2015
Q1 | $241K | Buy |
3,314
+314
| +10% | +$22.4K | 0.09% | 53 |
|
|
2014
Q4 | $207K | Buy |
+3,000
| New | +$202K | 0.08% | 53 |
|
Other funds holding LLY
Carlson Capital Management's LLY Position: Q4 2024 in Review
Carlson Capital Management reduced its Eli Lilly (LLY) stake by 79% in Q4 2024, selling an estimated $1.6M and leaving 513 shares worth $396K. The position accounts for 0.02% of the portfolio, ranked #83.
Carlson Capital Management first reported a position in LLY in Q4 2014 and has held it in 41 quarters since. The position peaked at $2.17M in Q3 2024. 3,906 funds tracked by Wall St. Rank hold LLY as of Q4 2024.
- Carlson Capital Management held 513 shares of Eli Lilly worth $396K as of Q4 2024.
- Carlson Capital Management sold 1,936 Eli Lilly shares in Q4 2024, an estimated $1.6M.
- Eli Lilly made up 0.02% of Carlson Capital Management's portfolio in Q4 2024, its #83 holding.
- Carlson Capital Management first reported a position in Eli Lilly in Q4 2014 and has held it in 41 quarters since.
- Carlson Capital Management's Eli Lilly position peaked at $2.17M in Q3 2024.
- 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.
Based on Carlson Capital Management's 13F filing for Q4 2024, filed 10 Feb 2025.